This activity is designed to provide hepatologists, and allied healthcare professionals with a comprehensive understanding of hepatocellular carcinoma (HCC), focusing on an introduction to hepato-oncology, systemic therapy for liver cancer, immunotherapy, patient selection, multidisciplinary care, and management of immune-related toxicities. Learners will gain practical, evidence-based knowledge to optimize patient outcomes and advance their expertise in hepato-oncology. At the completion of this activity, will receive a certificate in Hepato-oncology.
KEY TOPIC AREAS
Intro to Liver Cancer Systemic Therapy Certificate Program
Foundation of HCC
Principles of Systemic Therapy in Liver Cancer
Current Landscape of Systemic Therapy in Liver Cancer
Patient Selection
Response Criteria and Management
Training and Credentialing
Training and Credentialing Pathways
Best Practice
Panel Discussion
Release date: September 14, 2026
Expiration date: September 14, 2028
Time to complete each module: 30 minutes
CREDITS OFFERED
Continuing Medical Education (CME): For a maximum of 4.75 AMA PRA Category 1 Credits™
Continuing Education (CE): For a maximum of 4.75 Contact Hour
You may only earn one Continuing Education Credit type - either CME or CE
Maintenance of Certification (MOC): For a maximum of 4.75 MOC Points
COMPONENTS
Online presentations comprised of:
-10 online interactive, narrated modules 15 to 20 minutes in length
Post-test questions for each module
-Evaluation for CME or CE credit offering
DIRECTIONS
Click "Register" to activate the enduring material. Review all section tabs before you begin. Select module of interest. Complete all components to claim either CME or CE. MOC is available for learners who complete and earn CME.
COPYRIGHT
All faculty in this activity have given their permission for publication ©2021 AASLD.
CONTACT INFORMATION
For questions on CME and MOC content or LiverLearning®, contact online_education@aasld.org
For questions on CE credit for this enduring material, contact Certificate@AmedcoEmail.com